$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia 원문보기

Molecular psychiatry, v.6 no.2, 2001년, pp.230 - 234  

Basile, V S (Neurogenetics Section, Clarke Institute of Psychiatry, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada) ,  Ozdemir, V (Neurogenetics Section, Clarke Institute of Psychiatry, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada, and Department of Pharmacology, University of Toronto, Toronto, Canada) ,  Masellis, M (Neurogenetics Section, Clarke Institute of Psychiatry, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada) ,  Meltzer, H Y (Department of Psychiatry, Vanderbilt University, Nashville, USA) ,  Lieberman, J A (Department of Psychiatry, University of North Carolina, Chapel Hill, USA) ,  Potkin, S G (Department of Psychiatry, University of California, Irvine, USA) ,  Macciardi, F M (Neurogenetics Section, Clarke Institute of Psychiatry, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada) ,  Petronis, A (Neurogenetics Section, Clarke Institute of Psychiatry, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Canada) ,  Kennedy, J L (Neurog)

Abstract AI-Helper 아이콘AI-Helper

Tardive dyskinesia (TD) is a disabling neurological side effect associated with long-term treatment with typical antipsychotics. Family studies and animal models lend evidence for hereditary predisposition to TD. The newer atypical antipsychotics pose a minimal risk for TD which is in part attribute...

참고문헌 (25)

  1. J Clin Psychiatry GM Simpson 61 39 2000 10.4088/JCP.v61n0110 Simpson GM . The treatment of tardive dyskinesia and tardive dystonia J Clin Psychiatry 2000 61: (Suppl 4) 39-44 

  2. Biol Psychiatry J Bergen 32 580 1992 10.1016/0006-3223(92)90071-7 Bergen J, Kitchin R, Berry G . Predictors of the course of tardive dyskinesia in patients receiving neuroleptics Biol Psychiatry 1992 32: 580-594 

  3. J Clin Psychiatry P Weinhold 42 165 1981 Weinhold P, Wegner JT, Kane JM . Familial occurrence of tardive dyskinesia J Clin Psychiatry 1981 42: 165-166 

  4. Am J Psychiatry R Yassa 138 1618 1981 10.1176/ajp.138.12.1618 Yassa R, Ananth J . Familial tardive dyskinesia Am J Psychiatry 1981 138: 1618-1619 

  5. Br J Psychiatry JL Waddington 153 376 1988 10.1192/bjp.153.3.376 Waddington JL, Youssef HA . The expression of schizophrenia, affective disorder and vulnerability to tardive dyskinesia in an extensive pedigree Br J Psychiatry 1988 153: 376-381 

  6. Pharmacol Biochem Behav H Rosengarten 49 663 1994 10.1016/0091-3057(94)90085-X Rosengarten H, Schweitzer JW, Friedhoff AJ . Possible genetic factors underlying the pathophysiology of tardive dyskinesia Pharmacol Biochem Behav 1994 49: 663-667 

  7. Mol Psychiatry VS Basile 5 410 2000 10.1038/sj.mp.4000736 Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, et al. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia Mol Psychiatry 2000 5: 410-417 

  8. Neuropsychopharmacology H Hori 23 170 2000 10.1016/S0893-133X(99)00156-6 Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T et al. Manganese superoxide dismutase gene polymorphism and schizophrenia. Relation to tardive dyskinesia Neuropsychopharmacology 2000 23: 170-177 

  9. Basile VS, Masellis M, Ozdemir V, Meltzer HY, Macciardi FM, Kennedy JL . Application of pharmacogenetics of schizophrenia: emerging insights from studies of clozapine response and tardive dyskinesia In: Brier A, Tran PV, Herrera J, Bymaster F, Tollefson G (eds). Current Issues in the Psychopharmacology of Schizophrenia Lippincott Williams & Wilkins, New York 2000 (in press 

  10. Neuropsychopharmacology VS Basile 21 17 1999 10.1016/S0893-133X(98)00114-6 Basile VS, Masellis M, Badri F, Paterson AD, Meltzer HY, Lieberman JA et al. Association of the Mscl polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia Neuropsychopharmacology 1999 21: 17-27 

  11. Mol Psychiatry R Segman 4 247 1999 10.1038/sj.mp.4000511 Segman R, Neeman T, Heresco-Levy U, Finkel B, Karagichev L, Schlafman M et al. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia Mol Psychiatry 1999 4: 247-253 

  12. Mol Psychiatry VM Steen 2 139 1997 10.1038/sj.mp.4000249 Steen VM, Lovlie R, MacEwan T, McCreadie RG . Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients Mol Psychiatry 1997 2: 139-145 

  13. Br J Psychiatry M Armstrong 170 23 1997 10.1192/bjp.170.1.23 Armstrong M, Daly AK, Blennerhassett R, Ferrier N, Idle JR . Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype Br J Psychiatry 1997 170: 23-26 

  14. Neuropsychopharmacology HY Meltzer 21 106S 1999 10.1016/S0893-133X(99)00046-9 Meltzer HY . The role of serotonin in antipsychotic drug action Neuropsychopharmacology 1999 21: 106S-115S 

  15. Nature S Nedergaard 333 174 1988 10.1038/333174a0 Nedergaard S, Bolam JP, Greenfield SA . Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra Nature 1988 333: 174-177 

  16. Crit Rev Neurobiol BL Roth 12 319 1998 10.1615/CritRevNeurobiol.v12.i4.30 Roth BL, Berry SA, Kroeze WK, Willins DL, Kristiansen K . Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation Crit Rev Neurobiol 1998 12: 319-338 

  17. J Pharmacol Exp Ther HY Meltzer 251 238 1989 Meltzer HY, Matsubara S, Lee JC . Classification of typical and atypical antipsychotic drugs on the basis of dopamine-D-1, -D-2, and serotonin-2 pKi values J Pharmacol Exp Ther 1989 251: 238-246 

  18. Arch Gen Psychiatry NR Schooler 39 486 1982 Schooler NR, Kane JM . Research diagnoses for tardive dyskinesia Arch Gen Psychiatry 1982 39: 486-487 

  19. Neuropsychopharmacology M Masellis 19 123 1998 10.1016/S0893-133X(98)00007-4 Masellis M, Basile VS, Meltzer HY et al. Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients Neuropsychopharmacology 1998 19: 123-132 

  20. Science ES Lander 265 2037 1994 10.1126/science.8091226 Lander ES, Schork NJ . Genetic dissection of complex traits Science 1994 265: 2037-2048 

  21. Aberrant sequence or regulation? Neuropsychopharmacology A Petronis 23 1 2000 10.1016/S0893-133X(00)00127-5 Petronis A . The genes for major psychosis Aberrant sequence or regulation? Neuropsychopharmacology 2000 23: 1-12 

  22. Nucleic Acids Res DK Lahiri 19 5444 1991 10.1093/nar/19.19.5444 Lahiri DK, Nurnberger JI Jr . A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies Nucleic Acids Res 1991 19: 5444 

  23. Hum Mol Genet JT Warren 2 338 1993 10.1093/hmg/2.3.338 Warren JT, Jr, Peacock ML, Rodriguez LC, Fink JK . An Mspl polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis Hum Mol Genet 1993 2: 338 

  24. J Neurochem N Ozaki 68 2186 1997 10.1046/j.1471-4159.1997.68052186.x Ozaki N, Manji H, Lubierman V, Lu SJ, Lappalainen J, Rosenthal NE et al. A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization J Neurochem 1997 68: 2186-2193 

  25. Lancet MM Nothen 346 908 1995 10.1016/S0140-6736(95)92756-5 Nothen MM, Rietschel M, Erdmann J, Oberlander H, Moller HJ, Naber D et al. Genetic variation of the 5-HT2A receptor and response to clozapine Lancet 1995 346: 908-909 

관련 콘텐츠

원문 보기

원문 URL 링크

*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로